# India Fertility Services Market > India Fertility Services Market Research Report By Underlying Cause (Male Infertility, Female Infertility) and By Treatment Type (ART, Infertility Drugs) -Forecast to 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 17.5% - **2024:** $ 1.54 Billion - **2025:** $ 1.81 Billion - **2035:** $ 9.07 Billion - **Key Players:** Indira IVF (IN), Fortis La Femme (IN), Cloudnine Fertility (IN), Max Healthcare (IN), Apollo Fertility (IN), Nova IVF Fertility (IN), Lilavati Hospital (IN), Kiran Infertility Centre (IN), Sankalp Fertility (IN) **Report ID:** MRFR/HC/14651-HCR · **Pages:** 200 · **Author:** Rahul Gotadki · **Last Updated:** April 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/india-fertility-services-market-16178 --- ## Market Summary ## India Fertility Services Market Overview The India Fertility Services Market Industry is expected to grow from 2.64(USD Billion) in 2024 to 7.54 (USD Billion) by 2035. The India Fertility Services Market CAGR (growth rate) is expected to be around 10.01% during the forecast period (2025-2035). ### **Key India Fertility Services Market Trends Highlighted** The market for fertility services in India is expanding significantly at the moment due to a number of important factors. The demand for fertility treatments has increased as a result of growing awareness of infertility problems and an increase in the number of couples pursuing assisted reproductive technologies. Couples seek fertility treatments as a result of delayed marriage and childbirth brought on by urbanization and shifting lifestyle choices. Government programs that support access to healthcare are also helping the sector. The Indian fertility services market offers a wide range of opportunities. Artificial insemination and in-vitro fertilization (IVF) are two examples of cutting-edge technologies that are quickly gaining popularity and allowing service providers the opportunity to improve their services. Another strategic goal may be to expand into tier II and tier III cities, where services are few but awareness is rising. Growing partnerships between digital firms and reproductive clinics can enhance patient involvement and service delivery. Current patterns indicate a move toward more individualized fertility treatments, with clinics providing regimens that are customized to meet the needs of each patient. Additionally, there has been a noticeable rise in the acceptability and use of surrogacy services, donor eggs, and sperm, which is changing traditional perceptions of family planning in India. Additionally, new digital platforms are appearing that allow for distant consultations, meeting the increasing need for convenient service delivery. Fertility services are becoming more widely accepted as more people emerge out of the taboo and talk freely about infertility, which is securing the market's development trajectory in India. Source: Primary Research, Secondary Research, MRFR Database and Analyst Review ## **India Fertility Services Market Drivers** ### **Rising Infertility Rates** In India, the prevalence of[infertility](../../../reports/infertility-market-6145) has been steadily increasing, with data indicating that around 15-20% of couples experience fertility issues at some point in their lives. This rise is attributed to factors such as delayed marriage, lifestyle changes, and increased stress levels. The Indian government has recognized this pressing issue and has initiated various health programs aimed at addressing reproductive health, leading to increased awareness and demand for fertility services. Major organizations like the Federation of Obstetric and Gynecological Societies of India (FOGSI) have also started campaigns to promote reproductive health education, thus further driving the growth of the India Fertility Services Market Industry. As couples seek medical assistance, the demand for fertility services is expected to surge, propelling market growth strongly over the coming years. ### **Technological Advancements in Fertility Treatments** The India Fertility Services Market Industry is witnessing significant growth due to continuous advancements in medical technology. Techniques such as In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), and preimplantation genetic testing are now widely available, enhancing success rates for fertility treatments. A report by the Indian Society for Assisted Reproduction (ISAR) indicates a 30% increase in IVF success rates over the past five years, thanks to better technologies and techniques. This advancement not only improves outcomes but also raises public confidence in fertility services, fueling demand across the country. ### **Government Initiatives and Support** The Indian government has initiated various policies and programs to promote family planning and reproductive health, which have a direct impact on the India Fertility Services Market Industry. For instance, the National Health Policy emphasizes enhancing maternal and child health services, indirectly increasing accessibility to fertility treatments. Additionally, financial support and schemes for reproductive health have been introduced, enabling couples in various socio-economic brackets to access fertility services. Organizations such as the Ministry of Health and Family Welfare are crucial in implementing these programs, which undoubtedly facilitate market growth. ### **Increasing Awareness and Destigmatization of Fertility Treatments** There has been a significant shift in societal attitudes towards fertility treatments in India, with a growing acceptance and awareness among the population. Public educational campaigns led by organizations like the Indian Fertility Society (IFS) have played a crucial role in reducing the stigma associated with infertility and fertility treatments. Surveys indicate that approximately 70% of urban couples are now aware of fertility treatments, up from just 45% a decade ago. This increased awareness contributes to the growing demand for fertility services and underscores the potential for continued expansion in the India Fertility Services Market Industry. ## **India Fertility Services Market Segment Insights** ### **Fertility Services Market Underlying Cause Insights  ** The India Fertility Services Market is experiencing significant growth, particularly within the Underlying Cause segment, where Male Infertility and Female Infertility are prominent categories. Male Infertility, which encompasses various factors such as low sperm count, hormonal imbalances, and anatomical issues, is increasingly being recognized as a critical concern in reproductive health. Data shows that men account for approximately 40% of infertility cases in India, prompting a rising interest in treatments and interventions tailored to address these specific issues. On the other hand, Female Infertility, which can be attributed to conditions like ovulatory disorders, age-related factors, and structural abnormalities, also represents a significant portion of infertility cases, influencing a variety of treatment approaches and patient demographics. In India, numerous societal and health-related factors contribute to the prevalence of female infertility, including lifestyle changes, stress, and the increasing trend of delayed parenthood. This information indicates a substantial opportunity for fertility service providers to develop specialized treatments that cater to the unique needs of both genders. The dynamic landscape of the India Fertility Services Market reveals that advancements in assisted reproductive technology and increased awareness about infertility issues among the population are driving growth in both male and female infertility treatments. Moreover, raising educational initiatives regarding reproductive health and accessible healthcare options bolsters the market's opportunity to serve a broader audience. Increasing partnerships between hospitals and fertility clinics demonstrate the commitment to addressing these underlying causes effectively. As India continues to modernize in healthcare approaches, both Male Infertility and Female Infertility segments are positioned to play vital roles in the overall expansion of the India Fertility Services Market. The combination of cultural, socio-economic, and medical factors further illustrates the importance of addressing these underlying causes within India's larger reproductive health discourse. Source: Primary Research, Secondary Research, MRFR Database and Analyst Review ### **Fertility Services Market Treatment Type Insights  ** The Treatment Type segment of the India Fertility Services Market encompasses various methodologies that cater to the increasing demand for fertility solutions amid rising infertility rates in the country. Among these, Assisted Reproductive Technology (ART) plays a pivotal role, as it includes a range of advanced procedures like In-Vitro Fertilization (IVF) and Intracytoplasmic Sperm Injection (ICSI), which are gaining traction among couples seeking to conceive. The growing awareness around ART, bolstered by initiatives from healthcare providers and educational campaigns, is contributing to its significance within the market. On the other hand, infertility drugs remain a crucial aspect of fertility treatments, facilitating ovulation induction and enhancing reproductive outcomes. The increasing incidence of lifestyle-related infertility, coupled with rising healthcare expenditure in India, is propelling the demand for effective infertility drugs, thus making this segment vital for comprehensive treatment strategies. As the Indian demographic landscape continues to shift, with a higher prevalence of delayed parenthood, the intersection of technology and pharmaceuticals in the fertility domain is poised for considerable growth, driving innovations and improving access to reproductive health solutions in the country. The ongoing investment in fertility services reflects a commitment to address these evolving needs. ## **India Fertility Services Market Key Players and Competitive Insights** The India Fertility Services Market has emerged as a vital segment within the healthcare sector, responding to an increasing demand for reproductive health solutions. With the rise in awareness about infertility and advancements in reproductive technologies, various players in this market are enhancing their offerings to capture a larger share of this expanding sector. The competitive landscape is characterized by a diverse range of service providers, including standalone fertility clinics, multi-specialty hospitals, and integrated health organizations, all vying to meet the growing needs of patients seeking assisted reproductive technologies. As consumer preferences shift toward personalized and innovative treatments, companies in this market are investing in research and technological advancements to position themselves advantageously against competitors. Gurujan IVF has established itself as a significant player in the India Fertility Services Market, known for its specialized services and patient-centric approach. The clinic emphasizes the importance of individualized treatment plans and utilizes state-of-the-art technology to deliver high success rates in fertility treatments. Gurujan IVF's strength lies not only in its medical expertise but also in its comprehensive support services, which include counseling and psychological support for couples undergoing fertility treatments. The clinic has garnered a reputation for its high standards of care, making it a preferred choice among patients seeking fertility solutions in India. Its strategic locations across various regions also enhance its accessibility and market presence, allowing it to cater to a diverse patient base. Max Healthcare is another formidable player in the India Fertility Services Market, renowned for its comprehensive healthcare offerings, including advanced reproductive services. The organization has positioned itself as a leader in the field by integrating fertility treatments with its extensive network of hospitals and specialty clinics across the country. Max Healthcare's strengths lie in its experienced medical professionals, cutting-edge technology, and a holistic approach to patient care, offering services like in vitro fertilization, intrauterine insemination, and egg freezing. The company has engaged in strategic partnerships and collaborations to enhance its service offerings and extend its market footprint. Additionally, Max Healthcare's commitment to quality and safety standards, combined with its ongoing investment in research and development, further fortifies its competitive standing in the Indian fertility services space. These factors contribute to its reputation as a reliable provider for couples seeking assistance with reproductive health challenges in India. ### **Key Companies in the India Fertility Services Market Include** - Gurujan IVF - Max Healthcare - Apollo Fertility - IVF India - Morpheus IVF - [Nova IVF Fertility](https://novaivffertilitycentres.com/?source=Google&medium=CPC&campaignid=22205662045&adgroupid=176108835002&keyword=nova%20fertility%20ivf&device=c&network=g&gad_source=1&gad_campaignid=22205662045&gbraid=0AAAAADbZt8KXDG0P15zs0DOPdLK1sBpuP&gclid=CjwKCAjw56DBBhAkEiwAaFsG-quECxb-Vld45vayz-wk7srAobswzVHqfLsJ02GUZgQwHJadziexpBoChRIQAvD_BwE) - Lilavati Hospital and Research Centre - Sankalp Fertility - Cloudnine Fertility - Cocoon Fertility - Gaudium IVF - Milann - Crysta IVF - Fortis Bloom Fertility - Sparsh Hospital ## **India Fertility Services Market Industry Developments** The India Fertility Services Market has seen significant developments recently. In October 2023, Gurujan IVF launched a new state-of-the-art facility in Delhi, making advanced reproductive technologies more accessible. Additionally, Max Healthcare announced plans to expand its IVF services by introducing telemedicine consultations, responding to the growing trend of remote healthcare. Apollo Fertility has also made headlines by enhancing its services with the introduction of smart fertility monitoring solutions. Meanwhile, Nova IVF Fertility continues to grow in the North Indian region, with their recent partnership with local hospitals to improve patient access. In May 2023, IVF India expanded its operations in Maharashtra through the acquisition of a smaller clinic, which is expected to strengthen its market presence in that state. Recently, Morpheus IVF and Cloudnine Fertility have both reported increased market valuations attributed to higher demand driven by rising infertility rates in India, noted to be affecting approximately 27.5 million couples. The current market dynamics reflect changing societal norms and an increasing acceptance of assisted reproductive technologies, signaling a vibrant future for company expansions and service enhancements in this sector. ## **Fertility Services Market Segmentation Insights** ### **Fertility Services Market Underlying Cause Outlook** - Male Infertility - Female Infertility ### **Fertility Services Market Treatment Type Outlook** - ART - Infertility Drugs ## Market Drivers ### Rising Infertility Rates The increasing prevalence of infertility in India appears to be a primary driver for the India Fertility Services Market. Recent statistics indicate that approximately 10 to 15% of couples in India experience infertility issues, which translates to millions of individuals seeking assistance. Factors contributing to this rise include lifestyle changes, delayed marriages, and environmental influences. As awareness about fertility treatments grows, more couples are likely to explore options such as in vitro fertilization (IVF) and other assisted reproductive technologies. This trend suggests a robust demand for fertility services, thereby propelling the growth of the industry. ### Technological Innovations Technological advancements in reproductive medicine are significantly influencing the India Fertility Services Market. Innovations such as preimplantation [genetic testing,](https://www.marketresearchfuture.com/reports/genetic-testing-market-2009) cryopreservation techniques, and improved IVF protocols have enhanced success rates for fertility treatments. The introduction of artificial intelligence in patient management and treatment personalization is also gaining traction. As these technologies become more accessible, they are likely to attract a broader demographic seeking fertility solutions. The integration of advanced technologies not only improves treatment outcomes but also fosters patient confidence, which could lead to increased market penetration. ### Increased Awareness and Education The rising awareness and education surrounding fertility issues and treatments are crucial drivers for the India Fertility Services Market. Educational campaigns and outreach programs are helping to demystify infertility and the available solutions. As more individuals become informed about their reproductive health, they are more likely to seek assistance when facing challenges. This heightened awareness is also fostering a more supportive environment for those experiencing infertility, which could lead to increased utilization of [fertility services](https://www.marketresearchfuture.com/reports/fertility-services-market-6281). Consequently, the market is poised for growth as more couples recognize the options available to them. ### Government Initiatives and Support Government initiatives aimed at promoting reproductive health and family planning are likely to bolster the India Fertility Services Market. Various state and national programs are being implemented to raise awareness about infertility and available treatments. Financial assistance schemes and subsidies for fertility treatments are also being introduced, making services more affordable for a larger segment of the population. This proactive approach by the government may encourage couples to seek help sooner, thereby increasing the overall demand for fertility services in the country. ### Cultural Shifts Towards Family Planning Cultural shifts in India regarding family planning and reproductive health are emerging as a significant driver for the India Fertility Services Market. As societal norms evolve, there is a growing acceptance of assisted reproductive technologies among younger generations. Couples are increasingly prioritizing their careers and personal goals before starting families, leading to a rise in delayed parenthood. This trend is likely to result in a higher demand for fertility services as couples seek to conceive later in life. The changing perception of fertility treatments is expected to further normalize their use, contributing to market growth. ## Future Outlook The India Fertility Services Market is projected to grow at a 17.5% CAGR from 2025 to 2035, driven by increasing infertility rates, technological advancements, and rising awareness. **New opportunities:** - Expansion of telemedicine services for remote consultations Development of personalized fertility treatment plans using AI Investment in cryopreservation technologies for egg and sperm storage By 2035, the market is expected to be robust, driven by innovation and increased accessibility. ## Segment Insights ### By Underlying Cause: Female Infertility (Largest) vs. Male Infertility (Fastest-Growing) In the India Fertility Services Market, Female Infertility holds the largest share, primarily due to the increasing prevalence of conditions such as polycystic ovary syndrome (PCOS) and endometriosis. Cultural factors and the rising focus on women’s reproductive health further contribute to this dominant position. Male Infertility, while currently smaller in market share, is increasingly recognized, contributing to a shift in how infertility is perceived and treated in India, bolstered by growing awareness and education on the subject. Infertility Causes: Female Infertility (Dominant) vs. Male Infertility (Emerging) Female Infertility is characterized by a range of biological and health issues impacting women's ability to conceive, such as hormonal imbalances and age-related factors. This segment is often supported by a robust network of healthcare providers focusing on women's health, including advanced reproductive technologies like IVF and IUI. In contrast, Male Infertility is emerging as a critical area, driven by environmental factors and lifestyle changes. As awareness increases, more men seek diagnosis and treatment, which is leading to an expanding range of services dedicated to addressing male fertility issues. This dual focus illustrates a progressive shift in infertility services in India, with both segments evolving to meet changing societal norms. ### By Treatment Type: ART (Largest) vs. Infertility Drugs (Fastest-Growing) In the India Fertility Services Market, the market share distribution between Assisted Reproductive Technologies (ART) and Infertility Drugs varies significantly, with ART dominating the landscape. ART, encompassing procedures such as [in vitro fertilization (IVF)](https://www.marketresearchfuture.com/reports/in-vitro-fertilization-market-2289), accounts for the largest share of the market due to increasing awareness and acceptance of these technologies among couples facing fertility challenges. Infertility Drugs, while smaller in share, are rapidly gaining traction as a popular option for simpler treatments, complementing ART services effectively. The growth trends in this segment highlight the increasing investment in ART and infertility drug research as well as advancements in medical technologies. Factors such as the rising prevalence of infertility conditions, changing lifestyle patterns, and improved healthcare infrastructure are driving the demand for these treatments. Additionally, the growing acceptance and availability of various infertility drug options have made them a fast-growing segment within the overall fertility services market in India. ART (Dominant) vs. Infertility Drugs (Emerging) In the India Fertility Services Market, ART is recognized as the dominant treatment type, primarily due to its comprehensive approach and successful outcomes. ART comprises a range of advanced techniques, including IVF and ICSI, which have gained immense popularity among couples seeking solutions for infertility. These methods are often perceived as more effective, propelling ART to the forefront of fertility treatments. On the other hand, Infertility Drugs represent an emerging segment characterized by a surge in prescriptions and demand for hormonal treatments. These drugs usually serve as an initial intervention for couples trying to conceive, thus working alongside ART to enhance overall fertility outcomes. The growth of both treatment types showcases the evolving landscape of fertility services in India. ## Competitive Benchmarking The fertility services market in India is characterized by a dynamic competitive landscape, driven by increasing demand for assisted reproductive technologies (ART) and a growing awareness of fertility issues. Key players are actively positioning themselves through various strategies, including innovation, regional expansion, and partnerships. For instance, in October 2025, IVF Australia (AU) announced a strategic partnership with a local Indian healthcare provider to enhance its service offerings and accessibility in the region. This move reflects a broader trend among companies to localize their operations and cater to the specific needs of the Indian market, thereby shaping a more competitive environment. The market structure appears moderately fragmented, with numerous players vying for market share. Companies are employing tactics such as optimizing supply chains and localizing manufacturing to improve efficiency and reduce costs. The collective influence of key players, including Fertility Centers of Illinois (US) and CCRM Fertility (US), is notable as they leverage their expertise and technological advancements to gain a competitive edge. Their focus on patient-centric services and innovative treatment options is likely to enhance their market positioning. In September 2025, Fertility Centers of Illinois (US) expanded its operations by opening a new clinic in Mumbai, aiming to tap into the burgeoning demand for fertility services in urban areas. This expansion is strategically significant as it not only increases their footprint in a high-potential market but also allows them to offer tailored services that resonate with local patients. Such initiatives may enhance their brand visibility and patient trust, crucial factors in the fertility services sector. In August 2025, CCRM Fertility (US) launched a new telehealth platform designed to provide remote consultations and follow-up care for patients. This digital transformation initiative is indicative of the growing trend towards telemedicine in the fertility sector, particularly in light of the increasing reliance on technology for healthcare delivery. By integrating telehealth into their service model, CCRM Fertility (US) positions itself as a forward-thinking provider, likely attracting tech-savvy patients seeking convenience and accessibility. Current trends in the fertility services market are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence (AI) in treatment protocols. Strategic alliances among key players are shaping the landscape, fostering innovation and enhancing service delivery. As competition evolves, there is a discernible shift from price-based strategies to a focus on technological advancements and supply chain reliability. This transition suggests that companies that prioritize innovation and patient-centric solutions will likely emerge as leaders in the market. ## Recent News & Developments The India Fertility Services Market has seen significant developments recently. In October 2023, Gurujan IVF launched a new state-of-the-art facility in Delhi, making advanced reproductive technologies more accessible. Additionally, Max Healthcare announced plans to expand its IVF services by introducing telemedicine consultations, responding to the growing trend of remote healthcare. Apollo Fertility has also made headlines by enhancing its services with the introduction of smart fertility monitoring solutions. Meanwhile, Nova IVF Fertility continues to grow in the North Indian region, with their recent partnership with local hospitals to improve patient access. In May 2023, IVF India expanded its operations in Maharashtra through the acquisition of a smaller clinic, which is expected to strengthen its market presence in that state. Recently, Morpheus IVF and Cloudnine Fertility have both reported increased market valuations attributed to higher demand driven by rising infertility rates in India, noted to be affecting approximately 27.5 million couples. The current market dynamics reflect changing societal norms and an increasing acceptance of assisted reproductive technologies, signaling a vibrant future for company expansions and service enhancements in this sector. ## Report Scope | MARKET SIZE 2024 | 1.539(USD Billion) | | --- | --- | | MARKET SIZE 2025 | 1.809(USD Billion) | | MARKET SIZE 2035 | 9.074(USD Billion) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 17.5% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Billion | | Key Companies Profiled | Indira IVF (IN), Fortis La Femme (IN), Cloudnine Fertility (IN), Max Healthcare (IN), Apollo Fertility (IN), Nova IVF Fertility (IN), Lilavati Hospital (IN), Kiran Infertility Centre (IN), Sankalp Fertility (IN) | | Segments Covered | Underlying Cause, Treatment Type | | Key Market Opportunities | Integration of advanced reproductive technologies and personalized treatment plans in the India Fertility Services Market. | | Key Market Dynamics | Rising consumer awareness and technological advancements drive growth in India's fertility services market. | | Countries Covered | North America, Europe, APAC, South America, MEA | ## Frequently Asked Questions **Q: What is the current valuation of the India fertility services market?** A: The overall market valuation was $3500.0 Million in 2024. **Q: What is the projected market valuation for the India fertility services market by 2035?** A: The projected valuation for 2035 is $10250.0 Million. **Q: What is the expected CAGR for the India fertility services market during the forecast period 2025 - 2035?** A: The expected CAGR for the market during this period is 10.26%. **Q: Which treatment type holds the highest market value in the India fertility services market?** A: In Vitro Fertilization had a market value of $1400.0 Million in 2024. **Q: What is the market value for Intracytoplasmic Sperm Injection in 2024?** A: The market value for Intracytoplasmic Sperm Injection was $900.0 Million in 2024. **Q: How does the market value for Female Infertility compare to Male Infertility in 2024?** A: Female Infertility had a market value of $800.0 Million, while Male Infertility was valued at $600.0 Million in 2024. **Q: What segment is expected to grow the most in the India fertility services market?** A: The Treatment Services segment, valued at $2000.0 Million in 2024, is likely to see substantial growth. **Q: Which end user category had the highest market value in 2024?** A: Hospitals had the highest market value among end users, reaching $1400.0 Million in 2024. **Q: What is the market value for consultation services in the India fertility services market?** A: Consultation Services had a market value of $700.0 Million in 2024. **Q: Who are the key players in the India fertility services market?** A: Key players include IVF Australia, Fertility Centers of Illinois, and Bourn Hall Clinic, among others. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/india-fertility-services-market-16178*